Published in Clin Pharmacol Ther on March 01, 2000
A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria. PLoS One (2012) 1.02
Mechanisms of chloroquine-induced pruritus. Clin Pharmacol Ther (2000) 0.81
Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol (1983) 2.59
Abolition of cost-sharing is pro-poor: evidence from Uganda. Health Policy Plan (2005) 2.57
Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria. Br J Clin Pharmacol (1983) 1.77
Pruritus and antimalarial drugs in Africans. Lancet (1989) 1.70
Blood pressure, hypertension and correlates in urbanised workers in Ibadan, Nigeria: a revisit. J Hum Hypertens (1999) 1.54
Parenteral sulphadoxine-pyrimethamine (Fansidar): an effective and safe but under-used method of anti-malarial treatment. Trans R Soc Trop Med Hyg (1991) 1.48
Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum. Lancet (1987) 1.46
Malaria in Nigeria: a revisit. Ann Trop Med Parasitol (1990) 1.38
On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther (1983) 1.34
The disposition of amodiaquine in Zambians and Nigerians with malaria. Br J Clin Pharmacol (1990) 1.34
Characterization of chloroquine plasma protein binding in man. Br J Clin Pharmacol (1983) 1.21
Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase. A novel bifunctional enzyme in malaria parasites. Eur J Biochem (2001) 1.14
The disposition of chloroquine in healthy Nigerians after single intravenous and oral doses. Br J Clin Pharmacol (1987) 1.11
The in vivo sensitivity of Plasmodium falciparum to chloroquine and to sulphadoxine-pyrimethamine combination in Ibadan, Nigeria. Trans R Soc Trop Med Hyg (1981) 1.09
Glucose 6-phosphate dehydrogenase deficiency and sickle cell anemia: frequency and features of the association in an African community. Blood (1975) 1.08
Cerebral malaria in non-paediatric subjects resident in southwestern Nigeria. Afr J Med Med Sci (1993) 1.08
A longitudinal study of seroreactivities to Plasmodium falciparum antigens in Nigerian infants during their first year of life. Acta Trop (1995) 1.06
Genetic variation in the host and adaptive phenomena in Plasmodium falciparum infection. Ciba Found Symp (1983) 1.05
Comparison of the pharmacokinetics of chloroquine after single intravenous and intramuscular administration in healthy Africans. Br J Clin Pharmacol (1986) 1.03
Single dose disposition of chloroquine in kwashiorkor and normal children--evidence for decreased absorption in kwashiorkor. Br J Clin Pharmacol (1987) 1.01
Glucose-6-phosphate dehydrogenase deficiency. Baillieres Clin Haematol (1992) 0.99
Chloroquine sensitivity of Plasmodium falciparum in Ibadan, Nigeria: II. Correlation of in vitro with in vivo sensitivity. Trans R Soc Trop Med Hyg (1981) 0.99
Studies on Plasmodium falciparum parasitemia and development of anemia in Nigerian infants during their first year of life. Am J Trop Med Hyg (1996) 0.97
Retinal haemorrhage in cerebral malaria. East Afr Med J (1997) 0.96
Variation in the relationship between anti-MSP-1(19) antibody response and age in children infected with Plasmodium falciparum during the dry and rainy seasons. Acta Trop (2005) 0.95
Protein energy malnutrition and cerebral malaria in Nigerian children. J Trop Pediatr (1997) 0.92
Innate resistance to new antimalarial drugs in Plasmodium falciparum from Nigeria. Trans R Soc Trop Med Hyg (1992) 0.91
Hyponatraemia, birthweight and neonatal jaundice. Afr J Med Med Sci (1995) 0.89
Causes of death in childhood cancer at the Department of Paediatrics, University College Hospital, Ibadan. Afr J Med Med Sci (2008) 0.89
The clinical manifestations of cerebral malaria among Nigerian children with the sickle cell trait. Ann Trop Paediatr (1997) 0.87
Comparative efficacy of intramuscular artemether and intravenous quinine in Nigerian children with cerebral malaria. Acta Trop (1999) 0.87
Evaluation of the clinical efficacy and safety of halofantrine in falciparum malaria in Ibadan, Nigeria. Trans R Soc Trop Med Hyg (1991) 0.86
Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylate. Haematologica (2005) 0.86
Clinical efficacy of mefloquine in children suffering from chloroquine-resistant Plasmodium falciparum malaria in Nigeria. Trans R Soc Trop Med Hyg (1991) 0.85
Effect of HIV/AIDS on household welfare in Uganda rural communities: a review. East Afr Med J (2008) 0.85
Pharmacokinetics of quinine in African patients with acute falciparum malaria. Pharm World Sci (1998) 0.84
Detection of naphthols and aflatoxins in Nigerian cord blood. Ann Trop Paediatr (1994) 0.83
Platelet reactions after interaction with cultured Plasmodium falciparum infected erythrocytes. Br J Haematol (1987) 0.83
Stroke in Nigerian children with sickle cell disease. Afr J Med Med Sci (2005) 0.83
Pharmacokinetics of chloroquine in renal insufficiency. Afr J Med Med Sci (1985) 0.83
Chloroquine resistance of Plasmodium falciparum is associated with severity of disease in Nigerian children. Trans R Soc Trop Med Hyg (2002) 0.83
Sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Nigerian children. Bull World Health Organ (1990) 0.82
Evaluation of a rapid immunochromatographic card test for Plasmodium falciparum in Ibadan, Nigeria. Afr J Med Med Sci (2003) 0.82
The sensitivity of Plasmodium falciparum to chloroquine and amodiaquine in Ibadan, Nigeria. Trans R Soc Trop Med Hyg (1984) 0.81
The relationship between the response of Plasmodium falciparum malaria to mefloquine in African children and its sensitivity in vitro. Trans R Soc Trop Med Hyg (1992) 0.81
Effect of Plasmodium falciparum malaria on plasma fibrinopeptide-A (FpA) concentration. Cent Afr J Med (1995) 0.81
Influence of route of administration on the pharmaco-kinetics of chloroquine and desethylchloroquine. Bull World Health Organ (1987) 0.80
Pitfalls in the diagnosis of malaria: a-parasitaemic severe malaria. J Trop Pediatr (1992) 0.79
Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study. Ann Trop Med Parasitol (1992) 0.78
Hyperparasitaemia: not a reliable indicator of severity or poor prognosis in falciparum malaria in children in endemic African countries. Ann Trop Paediatr (1992) 0.78
Certain red cell genetic factors and prevalence of chloroquine-induced pruritus. Afr J Med Med Sci (2002) 0.78
Respiratory distress adversely affects the outcome of childhood cerebral malaria. Trans R Soc Trop Med Hyg (1996) 0.78
Therapeutic monitoring of chloroquine in pregnant women with malaria. West Afr J Med (2003) 0.78
Changes in lipid and lipoprotein values during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients. J Pak Med Assoc (1994) 0.78
Body temperature is a poor predictor of malaria parasitaemia in children with acute diarrhoea. Ann Trop Paediatr (1997) 0.77
Evaluation of lacidipine (a calcium blocker) in the treatment of hypertension in black African people: a double-blind comparison with hydrochlorothiazide. Afr J Med Med Sci (1999) 0.77
Neuropsychiatric side effects of mefloquine in Africans. Trans R Soc Trop Med Hyg (1993) 0.77
CHOLERA EPIDEMIOLOGY IN ZAMBIA FROM 2000 TO 2010: IMPLICATIONS FOR IMPROVING CHOLERA PREVENTION AND CONTROL STRATEGIES IN THE COUNTRY. East Afr Med J (2013) 0.77
Height and weight measurements of Ibadan school children. Afr J Med Med Sci (1996) 0.77
Identification of a subpopulation of immune Nigerian adult volunteers by antibodies to the circumsporozoite protein of Plasmodium falciparum. Am J Trop Med Hyg (1998) 0.77
Amlodipine as monotherapy in hypertensive Africans: clinical efficacy and safety studies. Afr J Med Med Sci (1996) 0.77
Comparison of the relative in vitro activity of chloroquine and amodiaquine against chloroquine-sensitive strains of P. falciparum. Ann Trop Med Parasitol (1987) 0.77
Parenteral therapy of moderately severe malaria: comparison of intramuscular artemether and intramuscular sulfadoxine-pyrimethamine. Trans R Soc Trop Med Hyg (1994) 0.76
Malaria and the problem of drug resistant Plasmodium falciparum. Afr J Med Med Sci (1993) 0.75
Biochemical changes during amlodipine treatment in hypertensive patients. Eur J Clin Pharmacol (1994) 0.75
Early deaths and other challenges to childhood cancer survival in Ibadan, Nigeria. Cent Afr J Med (2011) 0.75
Correlates of steady-state haematocrit and hepatosplenomegaly in children with sickle cell disease in Western Nigeria. West Afr J Med (2012) 0.75
Open trial of doxazosin in hypertensive Africans: dose finding, efficacy and safety studies. Afr J Med Med Sci (1996) 0.75
Breastfeeding and bloody diarrhoea in young children in Ibadan, Nigeria. J Trop Pediatr (1997) 0.75
Influence of baseline values. I: Effects on plasma total cholesterol and triglyceride levels during doxazosin treatment for hypertension. Int J Clin Pharmacol Res (1998) 0.75
Severe falciparum malaria: survival with oral therapy. Trop Geogr Med (1992) 0.75
Ectopia cordis in a Nigerian child. West Afr J Med (1994) 0.75
Assessment of a fixed-dosage combination of atenolol and chlorthalidone (Tenoretic) in hypertensive Nigerians. Afr J Med Med Sci (1990) 0.75
Hyperventilation-precipitated cerebrovascular accident in a patient with sickle cell anaemia. Afr J Med Med Sci (2001) 0.75
Breastfeeding and bloody diarrhoea in young children. J Trop Pediatr (1998) 0.75
Biochemical changes during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients. J Pak Med Assoc (1996) 0.75
Artemether in moderately severe and cerebral malaria in Nigerian children. Trans R Soc Trop Med Hyg (1994) 0.75
The effects of doxazosin on plasma lipid and lipoprotein levels in hypertensive patients. Pharmacol Res (1995) 0.75
Effects of moduretic on plasma lipid and lipoprotein levels in hypertensive African patients. Tokai J Exp Clin Med (1993) 0.75
Effects of amlodipine on plasma lipid and lipoprotein levels in hypertensive patients. J Intern Med (1992) 0.75
Biochemical changes during moduretic treatment of hypertension in African patients. Kobe J Med Sci (1995) 0.75
Duodenal intubation and aspiration test: utility in the differential diagnosis of infantile cholestasis. J Pediatr Gastroenterol Nutr (1991) 0.75